MedPath

Hexaell Biotech Co., Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

Phase 1
Recruiting
Conditions
Liver Failure
Hepatitis
Acute on Chronic Hepatic Failure
First Posted Date
2023-08-14
Last Posted Date
2025-02-25
Lead Sponsor
Hexaell Biotech Co., Ltd.
Target Recruit Count
92
Registration Number
NCT05989958
Locations
🇨🇳

Beijing You'an Hospital affiliated to Capital Medical University, Beijing, Beijing, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.